Walleye Capital’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.84M | Sell |
191,867
-77,271
| -29% | -$1.14M | 0.01% | 530 |
|
|
2025
Q1 | $4.82M | Sell |
269,138
-158,092
| -37% | -$2.83M | 0.02% | 365 |
|
|
2024
Q4 | $7.44M | Sell |
427,230
-61,223
| -13% | -$1.07M | 0.02% | 335 |
|
|
2024
Q3 | $6.83M | Buy |
488,453
+221,982
| +83% | +$3.11M | 0.01% | 352 |
|
|
2024
Q2 | $2.19M | Buy |
266,471
+254,096
| +2,053% | +$2.09M | ﹤0.01% | 774 |
|
|
2024
Q1 | $95.4K | Buy |
+12,375
| New | +$95.4K | ﹤0.01% | 2021 |
|
|
2023
Q4 | – | Sell |
-32,899
| Closed | -$294K | – | 3004 |
|
|
2023
Q3 | $294K | Sell |
32,899
-700,963
| -96% | -$6.27M | ﹤0.01% | 1347 |
|
|
2023
Q2 | $11.3M | Buy |
733,862
+692,631
| +1,680% | +$10.6M | 0.04% | 140 |
|
|
2023
Q1 | $927K | Sell |
41,231
-465,852
| -92% | -$10.5M | 0.01% | 765 |
|
|
2022
Q4 | $10.7M | Buy |
507,083
+168,659
| +50% | +$3.55M | 0.19% | 108 |
|
|
2022
Q3 | $8.34M | Buy |
338,424
+130,529
| +63% | +$3.22M | 0.16% | 133 |
|
|
2022
Q2 | $5.04M | Buy |
207,895
+41,375
| +25% | +$1M | 0.14% | 167 |
|
|
2022
Q1 | $4.29M | Buy |
166,520
+123,425
| +286% | +$3.18M | 0.11% | 178 |
|
|
2021
Q4 | $1.34M | Buy |
+43,095
| New | +$1.34M | 0.04% | 437 |
|
|
2021
Q3 | – | Sell |
-22,778
| Closed | -$332 | – | 1792 |
|
|
2021
Q2 | $332 | Buy |
22,778
+13,931
| +157% | +$203 | 0.01% | 875 |
|
|
2021
Q1 | $221 | Buy |
+8,847
| New | +$221 | 0.01% | 875 |
|
|
2020
Q1 | – | Sell |
-18,996
| Closed | -$269K | – | 948 |
|
|
2019
Q4 | $269K | Sell |
18,996
-58,681
| -76% | -$831K | 0.02% | 305 |
|
|
2019
Q3 | $900K | Buy |
+77,677
| New | +$900K | 0.05% | 52 |
|